Article: Allergan Releases Top-Line Results from Phase III Botox Headache Program.

HEALTH AND BEAUTY CLOSE-UP-16 September 2008-Allergan Releases Top-Line Results from Phase III Botox Headache Program(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com

Allergan announced that it has completed a top-line analysis of its two Phase III clinical trials exploring the use of Botox (botulinum toxin type A) for the prophylactic treatment of headache in adults suffering from chronic migraine - i.e., headaches and/or migraines that occur on 15 or more days each month.

In a release, the company noted:

Botox is the first therapy being investigated for this extremely debilitating condition of chronic migraine, which is estimated to affect ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!